Tag: Schizophrenia
Curaleaf Holding: Forging the largest acquisition in U.S cannabis landscape
The shares of Curaleaf (OTCQX: CURLF) surged by almost 15% since the news of its acquisition of Cura Partners, the owner of Select brand, in...
Acreage Holdings – “On a High” with news of Acquisition by...
The Canadian cannabis behemoth Canopy Growth Inc (NYSE:CGC), a global leader in diversified cannabis and hemp related products, entered into a definitive agreement with Acreage Holdings,...
Fighting Parkinson’s: Novel Therapeutics could prove to be game-changers
Parkinson’s is the second most common age-related neurodegenerative disorder, characterized by muscle rigidity, bradykinesia, cognitive impairment, etc. An estimated one million people in the...
New Age Therapeutics Offer Hope to Patients of Multiple Sclerosis
Multiple Sclerosis (MS) is one of the diseases that will be covered under the National Neurological Conditions Surveillance System (NNCSS), a system that is being built by the Centers...
CHALLENGING INSOMNIA BY INNOVATIVE RE-ENGINEERING OF THE NEURAL PATHWAYS
The Global Market for Insomnia is estimated to reach $5,488 million by 2023 from $4,093 million in 2016 at a CAGR of 4.2% according to a report...
We are looking for talented interns to learn and help investors find valuable companies.